These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33878029)

  • 1. Inactivation of SARS-CoV-2 Laboratory Specimens.
    Haddock E; Feldmann F; Shupert WL; Feldmann H
    Am J Trop Med Hyg; 2021 Apr; 104(6):2195-2198. PubMed ID: 33878029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
    Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S
    Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Different Inactivation Methods on Severe Acute Respiratory Syndrome Coronavirus 2 RNA Copy Number.
    Chen H; Wu R; Xing Y; Du Q; Xue Z; Xi Y; Yang Y; Deng Y; Han Y; Li K; Luan Y; Zhang Y; Wei X; Yu T; Li H; Zhu L; Su S; Lian H; Lu L; Tan C; Zheng H; Chen B; Yu P; Guo Y; Ma C
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32467359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
    Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
    Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of inactivation procedures for SARS-CoV-2.
    Auerswald H; Yann S; Dul S; In S; Dussart P; Martin NJ; Karlsson EA; Garcia-Rivera JA
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
    Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods.
    Xiling G; Yin C; Ling W; Xiaosong W; Jingjing F; Fang L; Xiaoyan Z; Yiyue G; Ying C; Lunbiao C; Liubo Z; Hong S; Yan X
    Sci Rep; 2021 Jan; 11(1):2418. PubMed ID: 33510320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.
    Patterson EI; Prince T; Anderson ER; Casas-Sanchez A; Smith SL; Cansado-Utrilla C; Solomon T; Griffiths MJ; Acosta-Serrano Á; Turtle L; Hughes GL
    J Infect Dis; 2020 Oct; 222(9):1462-1467. PubMed ID: 32798217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airborne Disinfection by Dry Fogging Efficiently Inactivates Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Mycobacteria, and Bacterial Spores and Shows Limitations of Commercial Spore Carriers.
    Schinköthe J; Scheinemann HA; Diederich S; Freese H; Eschbaumer M; Teifke JP; Reiche S
    Appl Environ Microbiol; 2021 Jan; 87(3):. PubMed ID: 33158901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19.
    Pawar SD; Khare AB; Keng SS; Kode SS; Tare DS; Singh DK; More RL; Mullick J
    Rev Sci Instrum; 2021 Aug; 92(8):081401. PubMed ID: 34470433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.
    Pastorino B; Touret F; Gilles M; Luciani L; de Lamballerie X; Charrel RN
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32521706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols.
    Kratzel A; Todt D; V'kovski P; Steiner S; Gultom M; Thao TTN; Ebert N; Holwerda M; Steinmann J; Niemeyer D; Dijkman R; Kampf G; Drosten C; Steinmann E; Thiel V; Pfaender S
    Emerg Infect Dis; 2020 Jul; 26(7):1592-1595. PubMed ID: 32284092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies.
    Eddins DJ; Bassit LC; Chandler JD; Haddad NS; Musall KL; Yang J; Kosters A; Dobosh BS; Hernández MR; Ramonell RP; Tirouvanziam RM; Lee FE; Zandi K; Schinazi RF; Ghosn EEB
    Immunohorizons; 2022 Feb; 6(2):144-155. PubMed ID: 35173021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma.
    Azhar EI; Hindawi SI; El-Kafrawy SA; Hassan AM; Tolah AM; Alandijany TA; Bajrai LH; Damanhouri GA
    Vox Sang; 2021 Jul; 116(6):673-681. PubMed ID: 33277935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients.
    Chen Z; Sikorski TW
    Bioanalysis; 2020 Sep; 12(17):1219-1222. PubMed ID: 32820941
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors affecting stability and infectivity of SARS-CoV-2.
    Chan KH; Sridhar S; Zhang RR; Chu H; Fung AY; Chan G; Chan JF; To KK; Hung IF; Cheng VC; Yuen KY
    J Hosp Infect; 2020 Oct; 106(2):226-231. PubMed ID: 32652214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol Susceptibility of SARS-CoV-2 and Other Enveloped Viruses.
    Nomura T; Nazmul T; Yoshimoto R; Higashiura A; Oda K; Sakaguchi T
    Biocontrol Sci; 2021; 26(3):177-180. PubMed ID: 34556620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
    Radbel J; Jagpal S; Roy J; Brooks A; Tischfield J; Sheldon M; Bixby C; Witt D; Gennaro ML; Horton DB; Barrett ES; Carson JL; Panettieri RA; Blaser MJ
    J Mol Diagn; 2020 Jul; 22(7):871-875. PubMed ID: 32405270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review.
    Paggiaro AO; Carvalho VF; Gemperli R
    Cell Tissue Bank; 2021 Mar; 22(1):1-10. PubMed ID: 33033963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disinfection of corona virus in histopathology laboratories.
    Luqman Z; Iqbal N; Ali HM; Zahid M; Sikandar A; Kausar R
    Clin Anat; 2020 Sep; 33(6):975-976. PubMed ID: 32533563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.